Searchable abstracts of presentations at key conferences in endocrinology

ea0063p602 | Diabetes, Obesity and Metabolism 2 | ECE2019

Platelet reactivity in patients with type 2 diabetes mellitus after treatment intensification with DPP-4i, SGLT-2i and GLP-1RA

Siasos Gerasimos , Paschou Stavroula A , Stampouloglou Panagiota K , Bletsa Evanthia , Batzias Konstantinos , Tsigkou Vasiliki , Antonopoulos Alexis , Oikonomou Evangelos , Gouliopoulos Nikolaos , Thanopoulou Anastasia , Noutsou Marina , Vryonidou Andromachi , Tentolouris Nikolaos , Tousoulis Dimitrios

Introduction: Patients with type 2 diabetes mellitus (T2DM) exert a higher risk for thrombotic events. Platelet reactivity may be used to assess prothrombotic state in such patients. The aim of this study was to investigate whether the administration of novel antidiabetic agents could influence the platelet reactivity in T2DM patients.Patients and methods: We enrolled 99 consecutive patients (males=63.3%), 64.92±8.3 years old, receiving metformin fo...